Comment
doi: 10.1016/S1473-3099(13)70112-9.
Epub 2013 Apr 30.
The end of the road for empirical antifungal treatment?
Affiliations
- PMID: 23639613
- DOI: 10.1016/S1473-3099(13)70112-9
Item in Clipboard
Comment
The end of the road for empirical antifungal treatment?
Lancet Infect Dis.
2013 Jun.
No abstract available
Comment on
-
Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial.Lancet Infect Dis. 2013 Jun;13(6):519-28. doi: 10.1016/S1473-3099(13)70076-8. Epub 2013 Apr 30. Lancet Infect Dis. 2013. PMID: 23639612 Clinical Trial.
Similar articles
-
Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial.Lancet Infect Dis. 2013 Jun;13(6):519-28. doi: 10.1016/S1473-3099(13)70076-8. Epub 2013 Apr 30. Lancet Infect Dis. 2013. PMID: 23639612 Clinical Trial.
-
Timing of broncho-alveolar lavage for galactomannan testing in hematological oncology patients.Clin Respir J. 2017 Jul;11(4):534-536. doi: 10.1111/crj.12380. Epub 2015 Oct 2. Clin Respir J. 2017. PMID: 26364561 No abstract available.
-
Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay.Clin Infect Dis. 2005 Jun 15;40(12):1762-9. doi: 10.1086/429921. Epub 2005 May 5. Clin Infect Dis. 2005. PMID: 15909264 Clinical Trial.
-
Prognostic value of galactomannan: current evidence for monitoring response to antifungal therapy in patients with invasive aspergillosis.J Pharmacokinet Pharmacodyn. 2017 Apr;44(2):143-151. doi: 10.1007/s10928-017-9509-1. Epub 2017 Feb 8. J Pharmacokinet Pharmacodyn. 2017. PMID: 28181136 Review.
-
[Aspergillus in airway material : Ignore or treat?].Internist (Berl). 2017 Nov;58(11):1150-1162. doi: 10.1007/s00108-017-0334-9. Internist (Berl). 2017. PMID: 28986661 Review. German.
Cited by
-
Survival Outcome of Empirical Antifungal Therapy and the Value of Early Initiation: A Review of the Last Decade.J Fungi (Basel). 2022 Oct 29;8(11):1146. doi: 10.3390/jof8111146. J Fungi (Basel). 2022. PMID: 36354913 Free PMC article. Review.
-
Predicting Invasive Aspergillosis in Hematology Patients by Combining Clinical and Genetic Risk Factors with Early Diagnostic Biomarkers.J Clin Microbiol. 2017 Dec 26;56(1):e01122-17. doi: 10.1128/JCM.01122-17. Print 2018 Jan. J Clin Microbiol. 2017. PMID: 29118175 Free PMC article.
-
Meta-Analysis and Cost Comparison of Empirical versus Pre-Emptive Antifungal Strategies in Hematologic Malignancy Patients with High-Risk Febrile Neutropenia.PLoS One. 2015 Nov 10;10(11):e0140930. doi: 10.1371/journal.pone.0140930. eCollection 2015. PLoS One. 2015. PMID: 26554923 Free PMC article. Review.
-
Comparison of Performance Characteristics of Aspergillus PCR in Testing a Range of Blood-Based Samples in Accordance with International Methodological Recommendations.J Clin Microbiol. 2016 Mar;54(3):705-11. doi: 10.1128/JCM.02814-15. Epub 2016 Jan 6. J Clin Microbiol. 2016. PMID: 26739157 Free PMC article.
-
Application of metagenomic next-generation sequencing in the diagnosis of pulmonary invasive fungal disease.Front Cell Infect Microbiol. 2022 Sep 27;12:949505. doi: 10.3389/fcimb.2022.949505. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 36237437 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
